Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Infect Dis ; 200(3): 379-89, 2009 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-19534597

RESUMEN

BACKGROUND: Recombinant forms of Neisseria meningitidis human factor H binding protein (fHBP) are undergoing clinical trials in candidate vaccines against invasive meningococcal serogroup B disease. We report an extensive survey and phylogenetic analysis of the diversity of fhbp genes and predicted protein sequences in invasive clinical isolates obtained in the period 2000-2006. METHODS: Nucleotide sequences of fhbp genes were obtained from 1837 invasive N. meningitidis serogroup B (MnB) strains from the United States, Europe, New Zealand, and South Africa. Multilocus sequence typing (MLST) analysis was performed on a subset of the strains. RESULTS: Every strain contained the fhbp gene. All sequences fell into 1 of 2 subfamilies (A or B), with 60%-75% amino acid identity between subfamilies and at least 83% identity within each subfamily. One fHBP sequence may have arisen via inter-subfamily recombination. Subfamily B sequences were found in 70% of the isolates, and subfamily A sequences were found in 30%. Multiple fHBP variants were detected in each of the common MLST clonal complexes. All major MLST complexes include strains in both subfamily A and subfamily B. CONCLUSIONS: The diversity of strains observed underscores the importance of studying the distribution of the vaccine antigen itself rather than relying on common epidemiological surrogates such as MLST.


Asunto(s)
Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Variación Genética , Meningitis Meningocócica/microbiología , Vacunas Meningococicas/genética , Neisseria meningitidis Serogrupo B/genética , Secuencia de Aminoácidos , Antígenos Bacterianos/química , Antígenos Bacterianos/metabolismo , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Europa (Continente)/epidemiología , Regulación Bacteriana de la Expresión Génica/fisiología , Humanos , Meningitis Meningocócica/epidemiología , Vacunas Meningococicas/química , Vacunas Meningococicas/metabolismo , Datos de Secuencia Molecular , Neisseria meningitidis Serogrupo B/inmunología , Neisseria meningitidis Serogrupo B/metabolismo , Nueva Zelanda/epidemiología , Sudáfrica/epidemiología , Estados Unidos/epidemiología
2.
J Clin Microbiol ; 42(11): 5146-53, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15528708

RESUMEN

The distribution of serogroups and multilocus sequence types (STs) in collections of disease-associated and carried meningococci from the period 1991 to 2000 in three European countries (the Czech Republic, Greece, and Norway) was investigated. A total of 314 patient isolates and 353 isolates from asymptomatic carriers were characterized. The frequency distributions of serogroups and clone complexes differed among countries and between disease and carrier isolate collections. Highly significant differentiation was seen at each housekeeping locus. A marked positive association of serogroup C with disease was evidenced. The ST-11 complex was strongly positively associated with disease; associations for other clone complexes were weaker. The genetic diversity of the clone complexes differed. A single ST dominated the ST-11 clone complex, while the ST-41/44 complex exhibited greater levels of diversity. These data robustly demonstrated differences in the distribution of meningococcal genotypes in disease and carrier isolates and among countries. Further, they indicated that differences in genotype diversity and pathogenicity exist between meningococcal clone complexes.


Asunto(s)
Portador Sano/epidemiología , Infecciones Meningocócicas/epidemiología , Neisseria meningitidis/clasificación , Neisseria meningitidis/genética , Portador Sano/microbiología , República Checa/epidemiología , Variación Genética , Genotipo , Grecia/epidemiología , Humanos , Infecciones Meningocócicas/microbiología , Neisseria meningitidis/aislamiento & purificación , Neisseria meningitidis/patogenicidad , Noruega/epidemiología , Serotipificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA